Increased expression of the pathological O-glycosylated form of oncofetal fibronectin in the multidrug resistance phenotype of cancer cells-Reference-Cited by-同舟云学术

Increased expression of the pathological O-glycosylated form of oncofetal fibronectin in the multidrug resistance phenotype of cancer cells

Published:2023-04 Issue: Volume:118 Page:47-68
ISSN:0945-053X
Container-title:Matrix Biology
language:en
Short-container-title:Matrix Biology

Author:

Reis Jhenifer Santos dos^ORCID,Santos Marcos André Rodrigues da Costa,da Costa Kelli Monteiro,Freire-de-Lima Celio Geraldo,Morrot Alexandre,Previato Jose Osvaldo,Previato Lucia Mendonça,da Fonseca Leonardo Marques^ORCID,Freire-de-Lima Leonardo^ORCID

Publisher

Elsevier BV

Subject

Molecular Biology

Reference102 articles.

1. Molecular mechanisms associated with chemoresistance in esophageal cancer;Lohan-Codeco;Cell. Mol. Life Sci.,2022

2. The multi-factorial nature of clinical multidrug resistance in cancer;Assaraf;Drug Resist. Updates,2019

3. Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives;Saunders;EMBO Mol. Med.,2012

4. ABC transporters in breast cancer: their roles in multidrug resistance and beyond;Modi;J. Drug Target,2022

5. Insights into new mechanisms and models of cancer stem cell multidrug resistance;Garcia-Mayea;Semin. Cancer Biol.,2020

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mucin Glycans: A Target for Cancer Therapy;Molecules;2023-10-11

2. Bittersweet Sugars: How Unusual Glycan Structures May Connect Epithelial-to-Mesenchymal Transition and Multidrug Resistance in Cancer;Medicines;2023-06-14

3. Golgi’s Role in the Development of Possible New Therapies in Cancer;Cells;2023-05-29

4. PDAC, the Influencer Cancer: Cross-Talk with Tumor Microenvironment and Connected Potential Therapy Strategies;Cancers;2023-05-26

5. The Role of Integrins for Mediating Nanodrugs to Improve Performance in Tumor Diagnosis and Treatment;Nanomaterials;2023-05-24